Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2026-03-05 @ 10:36 PM
Study NCT ID:
NCT01848834
Status:
COMPLETED
Last Update Posted:
2021-06-28
First Post:
2013-05-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-012/KEYNOTE-012)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05-07
Start Date Type:
ACTUAL
Primary Completion Date:
2016-04-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-03
First Submit QC Date:
None
Study First Post Date:
2013-05-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-04-07
Results First Submit QC Date:
None
Results First Post Date:
2017-06-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-28
Last Update Post Date:
2021-06-28
Last Update Post Date Type:
ACTUAL